Information on AGM9

Basic details

Name: Agammaglobulinemia 9 | Acronym: AGM9
Alt. names: ZIP7 deficiency | SLC39A7 deficiency

Gene: SLC39A7 | MOI: Autosomal recessive | Mechanism of action: Loss of Function

No. of cases in DB: 1 | First reported in: 2019

Last updated on: 2023-02-28 16:41:18 by

OMIM: 619693

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

A form of agammaglobulinemia that can be caused by biallelic loss of function mutations in the gene SLC39A7. It is characterized by early onset infections, blistering dermatosis, failure to thrive and thrombocytopenia

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

1 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code
101368arrow icon F 210392 46 1 German PMID:34975878 [Fam.F132:P132]

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Hepatopathyarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
2 Bronchiectasisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
3 Lung diseasearrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
4 Hepatitisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
5 Chronic obstructive pulmonary diseasearrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
6 Hypogammaglobulinemiaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
7 (unusual) Viral infectionarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
8 Hepatitis Carrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
9 Antineutrophil antibodiesarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
10 Antinuclear antibodiesarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
11 Rheumatoid factor positivearrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
12 Autoimmunityarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
13 Autoimmune antibody positivityarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.